{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:55:51Z","timestamp":1762505751086},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T00:00:00Z","timestamp":1305849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1007\/s10549-011-1564-5","type":"journal-article","created":{"date-parts":[[2011,5,19]],"date-time":"2011-05-19T05:33:18Z","timestamp":1305783198000},"page":"607-616","source":"Crossref","is-referenced-by-count":85,"title":["Biologic markers determine both the risk and the timing of recurrence in breast cancer"],"prefix":"10.1007","volume":"129","author":[{"given":"Laura J.","family":"Esserman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan H.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela J.","family":"Tsing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip W.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Yau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elissa","family":"Ozanne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vickram J.","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick L.","family":"Baehner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stig","family":"Kreps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew N. J.","family":"Tutt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl E.","family":"Gillett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher C.","family":"Benz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,20]]},"reference":[{"issue":"19","key":"1564_CR1","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T Sorlie","year":"2001","unstructured":"Sorlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98(19):10869\u201310874 Sep 11","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6871","key":"1564_CR2","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/415530a","volume":"415","author":"LJ van\u2018t Veer","year":"2002","unstructured":"van\u2018t Veer LJ, Dai H, van de Vijver MJ et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415(6871):530\u2013536 Jan 31","journal-title":"Nature"},{"key":"1564_CR3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-2164-7-96","volume":"7","author":"Z Hu","year":"2006","unstructured":"Hu Z, Fan C, Oh DS et al (2006) The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 7:96","journal-title":"BMC Genomics"},{"issue":"5","key":"1564_CR4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1634\/theoncologist.2007-0248","volume":"13","author":"JS Ross","year":"2008","unstructured":"Ross JS, Hatzis C, Symmans WF, Pusztai L, Hortobagyi GN (2008) Commercialized multigene predictors of clinical outcome for breast cancer. Oncologist 13(5):477\u2013493","journal-title":"Oncologist"},{"issue":"Suppl 3","key":"1564_CR5","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/bcr2430","volume":"11","author":"L Pusztai","year":"2009","unstructured":"Pusztai L (2009) Gene expression profiling of breast cancer. Breast Cancer Res 11(Suppl 3):S11","journal-title":"Breast Cancer Res"},{"key":"1564_CR6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/1471-2407-8-339","volume":"8","author":"A Tutt","year":"2008","unstructured":"Tutt A, Wang A, Rowland C et al (2008) Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature. BMC Cancer 8:339","journal-title":"BMC Cancer"},{"issue":"9460","key":"1564_CR7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(05)70933-8","volume":"365","author":"Y Wang","year":"2005","unstructured":"Wang Y, Klijn JG, Zhang Y et al (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365(9460):671\u2013679 Feb 19\u201325","journal-title":"Lancet"},{"issue":"10","key":"1564_CR8","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1073\/pnas.0409462102","volume":"102","author":"HY Chang","year":"2005","unstructured":"Chang HY, Nuyten DS, Sneddon JB et al (2005) Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci USA 102(10):3738\u20133743 Mar 8","journal-title":"Proc Natl Acad Sci USA"},{"issue":"27","key":"1564_CR9","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G et al (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351(27):2817\u20132826 Dec 30","journal-title":"N Engl J Med"},{"issue":"38","key":"1564_CR10","doi-asserted-by":"crossref","first-page":"13550","DOI":"10.1073\/pnas.0506230102","volume":"102","author":"LD Miller","year":"2005","unstructured":"Miller LD, Smeds J, George J et al (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci USA 102(38):13550\u201313555 Sep 20","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1564_CR11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/jnci\/djj052","volume":"98","author":"C Sotiriou","year":"2006","unstructured":"Sotiriou C, Wirapati P, Loi S et al (2006) Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 98(4):262\u2013272 Feb 15","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"1564_CR12","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/bcr2124","volume":"10","author":"P Wirapati","year":"2008","unstructured":"Wirapati P, Sotiriou C, Kunkel S et al (2008) Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res 10(4):R65","journal-title":"Breast Cancer Res"},{"issue":"16","key":"1564_CR13","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1158\/1078-0432.CCR-07-4756","volume":"14","author":"C Desmedt","year":"2008","unstructured":"Desmedt C, Haibe-Kains B, Wirapati P et al (2008) Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clin Cancer Res 14(16):5158\u20135165 Aug 15","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1564_CR14","doi-asserted-by":"crossref","first-page":"290","DOI":"10.5694\/j.1326-5377.1999.tb123656.x","volume":"171","author":"EA Lobb","year":"1999","unstructured":"Lobb EA, Butow PN, Kenny DT, Tattersall MH (1999) Communicating prognosis in early breast cancer: do women understand the language used? Med J Aust 171(6):290\u2013294 Sep 20","journal-title":"Med J Aust"},{"issue":"1","key":"1564_CR15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1369-6513.2001.00119.x","volume":"4","author":"EA Lobb","year":"2001","unstructured":"Lobb EA, Kenny DT, Butow PN, Tattersall MH (2001) Women\u2019s preferences for discussion of prognosis in early breast cancer. Health Expect 4(1):48\u201357","journal-title":"Health Expect"},{"issue":"12","key":"1564_CR16","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/bjc.1996.291","volume":"73","author":"MF Pichon","year":"1996","unstructured":"Pichon MF, Broet P, Magdelenat H et al (1996) Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers. Br J Cancer 73(12):1545\u20131551","journal-title":"Br J Cancer"},{"issue":"5","key":"1564_CR17","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","volume":"17","author":"JM Harvey","year":"1999","unstructured":"Harvey JM, Clark GM, Osborne CK, Allred DC (1999) Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17(5):1474\u20131481","journal-title":"J Clin Oncol"},{"issue":"5","key":"1564_CR18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","volume":"19","author":"CW Elston","year":"1991","unstructured":"Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19(5):403\u2013410","journal-title":"Histopathology"},{"key":"1564_CR19","unstructured":"Atkinson EJ, Therneau TM (2000) An introduction to recursive partitioning using the RPART routines"},{"key":"1564_CR20","volume-title":"Classification and regression trees","author":"L Breiman","year":"1984","unstructured":"Breiman L, Friedman J, Olshen R, Stone C (1984) Classification and regression trees. Wadsworth International Group, Belmont, CA"},{"issue":"7050","key":"1564_CR21","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature03799","volume":"436","author":"AJ Minn","year":"2005","unstructured":"Minn AJ, Gupta GP, Siegel PM et al (2005) Genes that mediate breast cancer metastasis to lung. Nature 436(7050):518\u2013524 Jul 28","journal-title":"Nature"},{"issue":"11","key":"1564_CR22","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1158\/1078-0432.CCR-06-2765","volume":"13","author":"C Desmedt","year":"2007","unstructured":"Desmedt C, Piette F, Loi S et al (2007) Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res 13(11):3207\u20133214 Jun 1","journal-title":"Clin Cancer Res"},{"issue":"6797","key":"1564_CR23","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406(6797):747\u2013752 Aug 17","journal-title":"Nature"},{"issue":"4","key":"1564_CR24","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1186\/bcr2138","volume":"10","author":"AE Teschendorff","year":"2008","unstructured":"Teschendorff AE, Caldas C (2008) A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer. Breast Cancer Res 10(4):R73","journal-title":"Breast Cancer Res"},{"issue":"5","key":"1564_CR25","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1186\/bcr2753","volume":"12","author":"C Yau","year":"2010","unstructured":"Yau C, Esserman L, Moore DH, Waldman F, Sninsky J, Benz CC (2010) A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer. Breast Cancer Res 12(5):R85 Oct 14","journal-title":"Breast Cancer Res"},{"issue":"6","key":"1564_CR26","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1186\/bcr2192","volume":"10","author":"F Reyal","year":"2008","unstructured":"Reyal F, van Vliet MH, Armstrong NJ et al (2008) A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer. Breast Cancer Res 10(6):R93","journal-title":"Breast Cancer Res"},{"issue":"6","key":"1564_CR27","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/sim.2655","volume":"26","author":"M Pintilie","year":"2007","unstructured":"Pintilie M (2007) Analysing and interpreting competing risk data. Stat Med 26(6):1360\u20131367 Mar 15","journal-title":"Stat Med"},{"issue":"5","key":"1564_CR28","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/1078-0432.CCR-07-1658","volume":"14","author":"MC Cheang","year":"2008","unstructured":"Cheang MC, Voduc D, Bajdik C et al (2008) Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 14(5):1368\u20131376 Mar 1","journal-title":"Clin Cancer Res"},{"issue":"5","key":"1564_CR29","doi-asserted-by":"crossref","first-page":"R68","DOI":"10.1186\/bcr2635","volume":"12","author":"A Prat","year":"2010","unstructured":"Prat A, Parker JS, Karginova O et al (2010) Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12(5):R68 Sep 2","journal-title":"Breast Cancer Res"},{"issue":"2","key":"1564_CR30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/107327480501200202","volume":"12","author":"TJ Hobday","year":"2005","unstructured":"Hobday TJ, Perez EA (2005) Molecularly targeted therapies for breast cancer. Cancer Control 12(2):73\u201381","journal-title":"Cancer Control"},{"issue":"3","key":"1564_CR31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa1011418","volume":"364","author":"J O\u2019Shaughnessy","year":"2011","unstructured":"O\u2019Shaughnessy J, Osborne C, Pippen JE et al (2011) Iniparib plus chemotherapy in metastatic triple-negative breast cancer. N Engl J Med 364(3):205\u2013214 Jan 20","journal-title":"N Engl J Med"},{"issue":"10","key":"1564_CR32","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1200\/JCO.1996.14.10.2738","volume":"14","author":"T Saphner","year":"1996","unstructured":"Saphner T, Tormey DC, Gray R (1996) Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol 14(10):2738\u20132746","journal-title":"J Clin Oncol"},{"issue":"9472","key":"1564_CR33","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"EBCTCG","year":"2005","unstructured":"EBCTCG (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687\u20131717 May 14\u201320","journal-title":"Lancet"},{"issue":"Suppl 1","key":"1564_CR34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10549-007-9698-1","volume":"105","author":"PE Goss","year":"2007","unstructured":"Goss PE (2007) Letrozole in the extended adjuvant setting: MA.17. Breast Cancer Res Treat 105(Suppl 1):45\u201353","journal-title":"Breast Cancer Res Treat"},{"issue":"19","key":"1564_CR35","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa032312","volume":"349","author":"PE Goss","year":"2003","unstructured":"Goss PE, Ingle JN, Martino S et al (2003) A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 349(19):1793\u20131802 Nov 6","journal-title":"N Engl J Med"},{"issue":"1","key":"1564_CR36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5858\/2007-131-18-ASOCCO","volume":"131","author":"AC Wolff","year":"2007","unstructured":"Wolff AC, Hammond ME, Schwartz JN et al (2007) American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 131(1):18\u201343","journal-title":"Arch Pathol Lab Med"},{"issue":"17","key":"1564_CR37","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/jnci\/djj329","volume":"98","author":"M Buyse","year":"2006","unstructured":"Buyse M, Loi S, van\u2019t Veer L et al (2006) Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst 98(17):1183\u20131192 Sep 6","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"1564_CR38","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1200\/JCO.2005.06.178","volume":"23","author":"IA Olivotto","year":"2005","unstructured":"Olivotto IA, Bajdik CD, Ravdin PM et al (2005) Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol 23(12):2716\u20132725 Apr 20","journal-title":"J Clin Oncol"},{"issue":"4","key":"1564_CR39","first-page":"165","volume":"55","author":"A Mrozkowiak","year":"2004","unstructured":"Mrozkowiak A, Olszewski WP, Piascik A, Olszewski WT (2004) HER2 status in breast cancer determined by IHC and FISH: comparison of the results. Pol J Pathol 55(4):165\u2013171","journal-title":"Pol J Pathol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1564-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-011-1564-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1564-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T12:56:39Z","timestamp":1637672199000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-011-1564-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,20]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["1564"],"URL":"https:\/\/doi.org\/10.1007\/s10549-011-1564-5","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,20]]}}}